Home›Search›Biologics: Targets and Therapy

Biologics: Targets and Therapy

Dove Medical Press Ltd. · New Zealand · Est. 2008

ISSN1177-5491

SJR Q1✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q178

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.989

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

1.273

Total Worksi

592

Total Citationsi

13,458

2yr Mean Citednessi

3.39

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

An international, peer reviewed journal focusing on the patho-physiological rationale for, and clinical application of, Biologic agents and their Biosimilars in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.

General Information

Country / RegionNew Zealand

Primary LanguageEnglish

1st Year Published2008

FrequencyAnnual, 2009-

StatusActive (last: 2026)

Total Publications592

Publisher OrgDove Medical Press

OA Since2007

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~16 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

9/12 · 75%

✅

Do you know the journal / publisher?

Dove Medical Press Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1177-5491

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

507

2019

232

2020

1.6k

2021

258

2022

2023

291

2024

105

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

GastroenterologyQ1

Pharmacology (medical)Q1

Immunology and AllergyQ2

OncologyQ2

RheumatologyQ2

Subject Classification

Web of Science Categories

Medicine, Research & Experimental

Scopus Categories

RheumatologyPharmacology (medical)Immunology and AllergyGastroenterologyOncology

Research Topics (OpenAlex)

Rheumatoid Arthritis Research and TherapiesMonoclonal and Polyclonal Antibodies ResearchBiosimilars and Bioanalytical MethodsPsoriasis: Treatment and PathogenesisSystemic Lupus Erythematosus ResearchSpondyloarthritis Studies and TreatmentsInflammatory Bowel DiseaseChronic Lymphocytic Leukemia ResearchLung Cancer Treatments and MutationsAutoimmune and Inflammatory Disorders Research

Frequently asked questions about Biologics: Targets and Therapy

Is Biologics: Targets and Therapy a predatory journal?

PubScope has no integrity flags on record for Biologics: Targets and Therapy: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Biologics: Targets and Therapy?

Biologics: Targets and Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 3.39.

Is Biologics: Targets and Therapy indexed in Scopus and Web of Science?

Biologics: Targets and Therapy is indexed in Web of Science, Scopus, DOAJ.